TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTCRYPTOMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTERTECHNOLOGY
Search

LATEST NEWS

The vaccine roll-out in Europe has been dominated by the product made by US firm Pfizer and its German partner BioNTech. Photo: EPA-EFE
Play
INVESTING

Vaccine Stocks Checkup: Johnson & Johnson Is Rising

Johnson & Johnson Lead
INVESTING

How to Trade Johnson & Johnson After It Reports Earnings

What Is Coinbase and How Do You Use It?
JIM CRAMER

Market Recap With Jim Cramer: Coinbase and Cathie Wood

PRESS RELEASES

Pfizer And BioNTech To Supply The European Union With 100 Million Additional Doses Of COMIRNATY®

Novavax Lead
INVESTING

15 Best Stocks in the Past Week: Novavax, Moderna Surge Higher

Chinese Cancer Drugs Developer CStone's Shares Surge On US$480 Million Deal With US Pharma Giant Pfizer
INVESTING

Stock Market Today With Jim Cramer: Buy These Stocks Over Pfizer

China's Health Care Sector Consolidation To Produce Global Champions, Says Investor In Newest Hong Kong IPO Winner
Video

Jim Cramer's Advice for Spotting a Healthcare Winner

  • Apr 16, 2021 1:57 PM EDT
jim-cramer-on-citigroups-downgrade-of-pfizer (3)
Video

Jim Cramer: Pfizer Doesn't Deserve to Be a Pariah

  • Apr 16, 2021 1:06 PM EDT
Moderna Lead
INVESTING

Moderna to Reduce Vaccine Deliveries in U.K., Canada

AstraZeneca Lead
INVESTING

AstraZeneca Cleared by FTC to Acquire Alexion

Jim Cramer Live 041621 Lead
JIM CRAMER

Jim Cramer on Pfizer, Bank Earnings and DraftKings

Johnson & Johnson Could Benefit From Tax Reform
INVESTING

Pfizer, Moderna Reportedly Decline J&J Request to Study Clot Risk

Stock Market Traders New York Stock Exchange
MARKETS

Dow 34,000, Morgan Stanley, DraftKings, Coinbase - 5 Things You Must Know

BioNTech and Pfizer's mRNA-based vaccine candidate BNT162b2 has proven to be more than 90 per cent effective in preventing Covid-19 infections. Photo: Reuters
INVESTING

Pfizer CEO Bourla: Vaccine Takers May Require Third Booster Dose

PRESS RELEASES

Pfizer Invites Shareholders To Attend Virtual-Only 2021 Annual Meeting Of Shareholders On April 22

New York Stock Exchange Lead
INVESTING

Nasdaq Set For Record High Into Coinbase Debut, Bank Earnings Lift Dow

Coronavirus: Pfizer And BioNtech To Seek Emergency US Approval 'within Days' After Better-than-expected Test Results
INVESTING

Pfizer Expanding Production of COVID-19 Vaccine by 10%

Jim Cramer: Johnson & Johnson Will Do Well With Actelion
INVESTING

Sell Johnson & Johnson After Vaccine Halt? See This Chart First

JJ_Vaccine_poster
Video

Johnson & Johnson's COVID-19 Vaccine Timeline

  • Apr 13, 2021 12:53 PM EDT
Johnson & Johnson's Profits Exceeds Analysts' Expectations
INVESTING

White House Says J&J Vaccine Pause Won't Deter Rollout

25Carnival-Victory carnival
INVESTING

Carnival and Other Cruise Stocks Fall on J&J Vaccine Pause

Vaccine Lead
INVESTING

Vaccine Stocks Checkup: Johnson & Johnson COVID-19 Vaccine Paused

No More Tears for Johnson & Johnson?
INVESTING

US CDC and FDA Pause Johnson & Johnson COVID Vaccine Use; Shares Slide

PRESS RELEASES

Myovant Sciences And Pfizer Announce First Participant Dosed In Phase 3 SERENE Study Evaluating Contraceptive Efficacy Of Once-Daily Relugolix Combination Tablet

Pinterest Lead
INVESTING

15 Best Stocks in the Past Week: Square, Roku, Pinterest